Europe Breast Pumps Market to Mark a Highest CAGR of 7.9% Through 2025: Grand View Research Inc.

 The Report Europe Breast Pumps Market Size, Share & Trends Analysis Report By Product (Open, Closed), By Technology (Manual, Electric), By Application (Personal, Hospital), And Regional Segment Forecasts, 2019 - 2025

The Europe breast pumps market size is expected to reach USD 676.53 million by 2025, according to a new report by Grand View Research, Inc. It is anticipated to register a CAGR of 7.9% during the forecast period. Increasing women employment, government initiatives aimed at improving consumer awareness, and improving healthcare infrastructure in emerging economies are the key driving factors.

Europe breast pumps market in developed economies, such as Germany, France, and Poland is saturated owing to increasing demand and presence of key market players. Economic development and rising disposable income are anticipated to help driving future sustainability for the regional market. Manufacturers investing in these rapidly developing markets are expected to witness high growth, provided pricing and distribution activities are undertaken effectively.

The end users in the Europe breast pump market, i.e. the lactating mothers, are becoming increasingly aware about the benefits and importance of breastfeeding. Increase in women employment and neonatal mortality rate is driving the adoption of advanced medical technologies in everyday lives of the consumers in this region. For instance, as per Global Economy, women employment rate in Germany increased from 54.51% in 2014 to 55.03% in 2017. Women in developed countries such as Germany and Poland are using technologically advanced devices in their everyday lives to reduce the time spent on routine activities. Such factors are anticipated to drive the regional market.

Access Research Report of Europe Breast Pumps Market @ https://www.grandviewresearch.com/industry-analysis/europe-breast-pumps-market

Further key findings from the report suggest:

• In terms of revenue, closed system segment is projected to ascend at the fastest CAGR over the forecast period. Ease of usage and better safety than the open system breast pumps can be attributed to the segment growth
• Electric breast pumps commanded the highest market share in 2017 and is expected to witness the fastest growth over the forecast period owing to the increase in inclination towards technologically advanced products
• Hospital grade breast pumps are expected to witness the fastest growth owing to the rising awareness regarding the benefit of breastfeeding and high employment rate among women
• Some of the key companies present in the Europe breast pumps market are Ameda; Energizer Holdings, Inc.; Medela AG; Koninklijke Philips N.V.; Büttner-Frank GmbH; and Pigeon Corporation.

Grand View Research has segmented the Europe breast pumps market on the basis of product, technology, application, and region:

Europe Breast Pump Product Outlook (Volume, Units; Revenue USD Million, 2014 - 2025)

• Open System
• Closed System

Europe Breast Pump Technology Outlook (Volume, Units; Revenue USD Million, 2014 - 2025)

• Manual
• Battery Powered
• Electric

Europe Breast Pump Application Outlook (Volume, Units; Revenue USD Million, 2014 - 2025)

• Personal Use
• Hospital Grade

Europe Breast Pump Country Outlook (Volume, Units; Revenue USD Million, 2014 - 2025)

• Greece
• Italy
• Germany
• Poland
• France

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Ophthalmic Packaging Market Set to Record Exponential Growth by 2026: Grand View Research Inc.

 Ophthalmic Packaging Market Growth & Trends

The global ophthalmic packaging market is expected to reach USD 15.20 billion by the end of 2026, according to a new report by Grand View Research, Inc. It is projected to expand at a 9.9% CAGR over the forecast period.  Increasing global burden of ocular conditions and growing number of ophthalmic clinics, hospitals, and ambulatory care centers are the factors driving the market growth. Additionally, frequent introduction of new drug delivery systems and high demand for advanced packaging solutions is expected to fuel the market during forecast period.

Increasing healthcare expenditure and rising disposable income are some of the prominent factors that are expected to drive a lot of patients towards advanced ophthalmic care. Furthermore, growing number of advanced healthcare facilities such as eye hospitals and ophthalmic clinics across several regions and increasing awareness about preventive care, ocular disorders and self-medications are some of the factors expected to aid to the market growth.

Increasing geriatric population coupled with age related ocular disorders is expected to increase the demand for ophthalmic products. Furthermore, the improving reimbursement policies for ocular surgeries including cataract & eye implants and increasing awareness about ocular disorders and treatment options is expected to drive the market growth.

The government and non-government initiatives such as ocular screening program and national healthcare program is expected to increase the accessibility to ophthalmic healthcare. Furthermore, the initiatives such as “economical free trade zone” & reducing approval time for establishment of facilities will contribute to the establishment of new ophthalmic manufacturing facilities that is expected to increase the demand for the packaging materials over the forecast period.

Request a free sample copy or view report summary: Ophthalmic Packaging Market Report

Ophthalmic Packaging Market Report Highlights

• Multiple dose ophthalmic packages held the largest market share in 2018 and expected to grow at a significant rate over the forecast period. Increasing usage of multiple dose packaging in OTC preparations coupled with growing prevalence of common ocular disorders such as red eyes, dry eyes, and conjunctivitis are the major factors expected to drive the growth.
• Based on material, plastics packaging material accounted for the largest share and is expected to grow at a significant rate over the forecast period. Low density polyethylene (LDP) is the most preferred used resins due its advantages such as flexibility, compatibility, affordability and safety.
• Based on type the ophthalmic packaging market is segmented into prescription and over the counter (OTC) products. The prescription type segment held the largest share in 2018 and is expected to grow at significant rate over the forecast period.
• North America held around 38.5% of the global ophthalmic packaging material market in 2018. Developed healthcare infrastructure, rising ageing population, prevalence of eye disorders, and presence of stringent regulatory bodies are the factors contributing to the significant share.
• Asia Pacific is anticipated to grow at fastest CAGR over the forecast period, the presence of several small and large scale ophthalmic manufacturing plants and large unmet healthcare needs.

Ophthalmic Packaging Market Segmentation

Grand View Research has segmented the ophthalmic packaging market on the basis of dose, type, material and regions:

Dose Outlook (Revenue, USD Million, 2015 - 2026)

• Multi dose
• Single dose

Type Use Outlook (Revenue, USD Million, 2015 - 2026)

• OTC
• Prescription

Material Outlook (Revenue, USD Million; 2015 - 2026)

• Glass
• Plastic
• Others

Regional Outlook (Revenue, USD Million, 2015 - 2026)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • Japan
  • India
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Expansion of Weight Loss Services Market During 2019 – 2025 to Gain Robust Traction: Grand View Research Inc.

 Weight Loss Services Market Growth & Trends

The global weight loss services market size is expected to reach USD 21.1 billion by 2025 expanding at a CAGR of 8.4%, according to a new report by Grand View Research, Inc. Rising cases of obesity and resultant health consciousness along with increased per capita healthcare expenditure are the key factors fueling the market growth. Obesity is among the major health concerns that lead to a number of associated diseases or complications, such as diabetes, Cardiovascular Diseases (CVDs), and cancers. For instance, as per WHO, in 2016, more than 1.9 billion adults were overweight, out of which around 650 million people were obese.

Such instances are expected to encourage people to maintain proper health to help lower the risk of such chronic health issues, thereby augmenting market growth. Key companies in the market are focusing on the development of new ways for weight loss, such as Zumba, sports-specific performance training, aquatic exercise classes, and weight loss supplements. For instance, in August 2018, Herbalife International launched Herbalife24 ACHIEVE protein bar, a convenient, energy-providing snack. This product launch may increase the company’s popularity among athletes worldwide. Hence, such initiatives are anticipated to drive the market.

Request a free sample copy or view report summary: Weight Loss Services Market Report

Weight Loss Services Market Report Highlights

• Fitness equipment segment is estimated to register the highest CAGR over the forecast period due to advancements by key companies, in terms of technology and equipment
• Consulting services is projected to expand at the highest CAGR due to their cost-effectiveness as compared to other services
• APAC is expected to be the fastest-growing regional market in future. Increasing cases of obesity and diabetes due to changing lifestyles are anticipated to drive the region’s growth
• Some of the key companies in the global weight loss services market are Atkins Nutritionals, Inc.; Nutrisystem, Inc.; Herbal Life International, Inc.; Apollo Endosurgery, Inc.; Johnson Health Tech; WW International, Inc.; Kellogg Co; Amer Sports; Cynosure, Inc.; and Diet Health, Inc.

Weight Loss Services Market Segmentation

Grand View Research has segmented the global weight loss services market on the basis of equipment, service, payment, and region: 

Weight Loss Services Equipment Outlook (Revenue, USD Billion, 2014 - 2025)

• Fitness Equipment
  • Cardiovascular Equipment
  • Strength Training Equipment
  • Infrared Light Therapy Equipment
  • Others
• Surgical Equipment
  • Bariatric Surgery Equipment
  • Non-invasive Surgical Equipment

Weight Loss Services Outlook (Revenue, USD Billion, 2014 - 2025)

• Fitness Centers
• Slimming Centers
• Consulting Services
• Surgery
• Other Services

Weight Loss Services Payment Outlook (Revenue, USD Billion, 2014 - 2025)

• Government
• Private Insurance
• Out of Pocket

Weight Loss Services Regional Outlook (Revenue, USD Billion, 2014 - 2025)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Greece
  • Denmark
• Asia-Pacific
  • Japan
  • China
  • India
• Latin America
  • Brazil
  • Mexico
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Cold Plasma Market to Reflect Robust Expansion During 2019-2026: Grand View Research Inc.

 Cold plasma, also known as non-equilibrium plasma, is the plasma where the individual constituents each have different temperatures, with electrons being at a higher temperature of more than 10,000 K, with the neutral atoms being at room temperature. When cold plasma reacts with an open or controlled environment, it produces many reactive species that can be used in a number of scientific chemical reactions. Cold plasma finds application in a number of areas such as biomedicine, food industry and environmental sciences, among others.

The rise in the number of hospital admissions across the globe, leading to subsequent increase of hospital acquired infections (HAIs), is a major factor in the high demand for the cold plasma market. According to CDC estimates for American hospitals, HAIs account for an estimated 1.7 million infections and 99,000 associated deaths each year, with the prevalence of HAIs in 1 out of 31 patients every day; moreover, according to the WHO, out of 100 hospitalized patients at any given point of time, 10 patients in developing countries and 7 in developed ones acquire at least 1 HAI. Cold plasma is very effective in deactivating antibiotic resistant bacterial strains.

An important property of cold plasma is the ability to kill bacteria and prevent infection, while it also helps in accelerating the healing process in patients, thus lessening patient discomfort and hospital stay. An article in the National Library of Medicine states that the UK sees 4.5 million patients in Europe annually suffer from hospital acquired infections, on account of the rising number of multi-resistant micro-organisms. Cold atmospheric pressure plasma has shown antimicrobial, antifungal and antiviral properties, which is expected to aid market growth.

Cold plasma has been found to be effective in cases of chronic wounds and burns, as well as in the cases of non-healing wounds. The rising prevalence of diabetes, anemia and cancer is a factor in the large number of cases of non-healing wounds, with 4 million people in Europe suffering from these wounds each year. Burn injuries can be treated directly using cold plasma, as it generates free radicals which prevent wound infection. The National Center for Biotechnology Information (NCBI) published a research in 2017, wherein a patient suffering with two second-degree burns was treated with cold plasma, which healed the itching and pain and presented new tissue after a second treatment. Such results can potentially expand the cold plasma market in new directions in the coming years.

In terms of pressure type, the cold plasma market has been segmented into low-pressure cold plasma and atmospheric pressure cold plasma. The cold atmospheric pressure plasma (CAPP) segment is expected to show fastest growth in the market in coming years, on account of its widespread use in healthcare applications such as biofilm removal, surface decontamination, infection control, wound healing, and burn treatment, as well as various surgical and non-surgical procedures. Moreover, developments in cancerous cell treatments are also expected to aid in the segment growth.

Based on application, the cold plasma market is segmented into wound healing, blood coagulation, dentistry and cancer treatment, among other medical applications. The wound healing segment accounts for the largest market share, as cold plasma accelerates wound healing process by inactivating multi-drug resistant (MDR) bacterial strains. Cancer treatment is another area that holds positive growth for the market in the near future, as cold plasma has shown effectiveness in the pre-clinical model of skin, brain, lung, breast, bladder, head, and neck cancer.

Region-wise, the cold plasma market accounts for a substantial market share, due to the presence of various major industry players, coupled with availability of various FDA-approved products. The continued technological advancements, along with the high prevalence of cancer cases in the region, is also abetting market growth. According to the National Cancer Institute, the US is expected to witness 606,520 deaths due to cancer in 2020, which calls for advancements in cancer treatment techniques, on of which is cold atmospheric pressure plasma. Europe is expected to remain an attractive market, on account of the high prevalence of HAIs in the region; Asia Pacific is also expected to show substantial market growth, with the rapid developments in treatment procedures and the ever-expanding medical tourism sector.

Request a free sample copy or view report summary: Cold Plasma Market Report

Recent Trends and Developments

The global COVID-19 outbreak has led to medical institutions facing shortage of medical equipment, which necessitates the reuse of such products. With this aim, an engineering team at the George Washington University has undertaken the development of a ‘plasma brush’ that can decontaminate protective masks, gloves and other necessary gear for reuse. The development builds on the use of cold plasma for cancer treatment, and is expected to cleanse equipment, surfaces and even small-space airflow. Such advances can boost the market growth for cold plasma in the coming months.

A plasma medicine research carried out in May 2020 by researchers from Penn State's College of Engineering, College of Agricultural Sciences and College of Medicine established the effectiveness of direct LTP treatment and plasma-activated media against bacteria found in liquid culture. The team also has applied its findings to design a system that can create plasma directly in liquids, and specifically blood, in order to combat cardiovascular infections at the source. These findings are expected to widen the scope of the cold plasma market.

In January 2020, a surgical team at The Chaim Sheba Medical Center in Tel HaShomer, Israel, with coordination by US Medical Innovations, LLC (USMI), successfully used the Canady Helios™ Cold Plasma Scalpel (CHCPS) for a rare advanced reoccurring inoperable retroperitoneal sarcoma. The CHCPS specifically eradicates microscopic remnants of cancer cells while sparing normal cells and tissue. The patient in question was a 33-year-old man with a rare inoperable Retroperitoneal Sarcoma. The device underwent further clinical trials in February 2020.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Biomedical Refrigerators & Freezers Market Will Target Emerging Markets by 2024

 Biomedical refrigerators involve the equipment that can store biological samples such as blood and its derivatives, biological reagents, vaccines and medicines, along with RNA and DNA samples, for a sufficiently long period of time. The RNA and DNA samples can be stored in the temperature range of -70°C to -80°C, and even lower; while vaccines and plasma products can be stored in plasma freezers between the temperatures -30°C to -40°C.

The global market for biomedical refrigerators and freezers is expected to grow at an appreciable rate in the coming years, on account of multiple factors such as growing prevalence of chronic diseases, the increase in demand for storing biological products, along with blood samples, blood reagents, vaccines, DNA samples and other chemicals. The CDC issues guidelines and specifications for the proper vaccine storage, failing which they would lose their potency, which would result in little to no immune response from the recipient. The market has also grown rapidly out of the need to avoid vaccine wastage; according to the NHS, £5 million worth of vaccines were wasted in 2017 alone, with refrigeration failure and storing or transporting out of the cold chain being two of the major causes.

With the current global COVID-19 pandemic, the testing of samples has become a critical and time intensive process, with the specimen collection regarding SARS CoV-2 calling for proper handling and storage. As they are required to be kept at low temperatures, it is expected that there would be a high demand for biomedical refrigerators and freezers in the coming weeks and months. Moreover, the most-affected regions such as North America, Western Europe and Asia Pacific would be seeing an increase in demand for equipment at medical institutions, which is a trend that would positively affect the biomedical refrigerators and freezers market.

Based on product type, the biomedical refrigerators and freezers market can be segmented into blood bank refrigerators, shock, plasma and ultra-low temperature freezers, laboratory/pharmacy/medical freezers, laboratory/pharmacy/medical refrigerators. Plasma freezers segment is expected to show substantial growth in the coming years, as they are used in the process of therapeutic plasma exchange (plasmapheresis), which according to the European Society of Hemapheresis (ESFH), is the most frequently performed apheresis technique, being used in the treatment of side effects of small cell lung and breast cancers, as well as colon cancer and Hodgkin’s disease.

In terms of end-use, the biomedical refrigerators and freezers market is segmented into hospitals, pharmacies, laboratories, diagnostic centers, and blood banks. Blood banks emerged as the biggest end-use segment, due to the rising awareness among consumers regarding blood donations and government initiatives to promote them. Moreover, there are organizations in place to monitor the storage of immunobiologics and blood components, such as the Center for biologics evaluation and research (CBER) in the US. The pharmacy segment is anticipated to show fastest growth in the near future, on account of the rising number of adverse reactions and increasing wastage of vaccines due to thermal shock.

According to the American Red Cross organization, the U.S. sees 21 million blood components being transfused each year. However, the current exceptional scenario created by the coronavirus pandemic has led to cancellation of blood drives, resulting in shortage of blood stored. Moreover, the country requires 36,000 units of red blood cells, 7000 units of platelets, and 10,000 units of plasma every day. With the rising need for blood transfusions, it is also required that the units be properly stored in order to avoid the risk of blood transfusion errors. These factors have led to the growth of the blood bank segment, while it is expected to grow at a substantial rate in the near future.

Region-wise, North America, and more particularly the U.S., holds substantial share in the biomedical refrigerators and freezers market, on account of the high expenditure on hospitals and healthcare infrastructure in the region, as well as the high prevalence of chronic diseases that has led to an increasing number of blood transfusion procedures. Another region that is expected to contribute significantly to the market is Asia Pacific, with the development of healthcare infrastructure in rapidly emerging economies such as India, China and Indonesia expected to aid in the regional market growth by 2024.

Request a free sample copy or view report summary: Biomedical Refrigerators & Freezers Market Report

Recent Developments

In March 2020, PHC Corporation of North America announced that it would accelerate the delivery of critical equipment to the facilities that are working on COVID-19 diagnostics, clinical care, vaccine development and research. The products include high performance refrigerators and biomedical freezers, ultra-low temperature storage freezers, CO2 and multi-gas CO2/O2 incubators, and class II, type A2 biological safety cabinets.

In February 2020, Haier Biomedical donated a solar direct drive vaccine fridge to Abuja Primary Healthcare in Nigeria. The fridge provides temperature protection, security and safety for vaccine storage. The product can be efficiently used even during power shortages by maintaining the right temperature for vaccines.

In October 2019, the US Environmental Protection Agency recognized the Helmer Scientific GX Solutions laboratory, pharmacy, and blood bank single and double door upright refrigerators, as meeting the ENERGY STAR® energy efficiency requirements for High Performance Laboratory Refrigerators. The products are powered by the OptiCool™ technology.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Healthcare Staffing Market Value Expected To Increase at a CAGR of 5.4% from 2020 to 2027: Grand View Research Inc.

Healthcare Staffing Market Growth & Trends

The global healthcare staffing market size is likely to reach USD 48.6 billion by 2027 at a CAGR of 5.4% over the forecast period, based on a new report by Grand View Research, Inc. The rising demand for temporary nursing staff especially due to growing geriatric population is boosting the scope for these services across the world.

In 2010, the Association of American Medical Colleges estimated that U.S. might face a shortfall of 150,000 doctors during the next 10-15 years. In August 2019, the National Association of Locum Tenens Organizations (NALTO) stated that 90% of the U.S. healthcare facilities use locum tenens providers and over 50,000 physicians work on locum tenens projects every year. The increasing number of physicians choosing to work as locum tenens is expected to propel the market growth over the forecast period.

Furthermore, the hospitals are forced to reduce the staff and implement policies for ensuring the availability of nurses upon an increase in the workload, in response to the pressure of costs. Due to high penetration of the market, there is the availability of healthcare staff during emergencies, thereby driving the market growth.

Request a free sample copy or view report summary: Healthcare Staffing Market Report

Healthcare Staffing Market Report Highlights

• By service, the market has been segmented into travel nurse, per diem nurse, locum tenens, and allied healthcare, out of which, the travel nurse segment dominated the market in terms of revenue share in 2019
• Locum tenens are anticipated to witness a significant growth rate over the forecast period owing to rising number of physicians opting to work as locum tenens and due to the cost-effectiveness to the providers
• North America held a majority of the market share in 2019 due to shortage of skilled professionals in the region, local presence of several market players, and overall growth in geriatric population
• Asia Pacific is expected to register the highest growth rate over the forecast period due to increasing awareness regarding contract staffing, promising economic outlook, and increasing investments by various market players
• Some of the key players operating in the healthcare staffing market are AMN Healthcare; Envision Healthcare Corporation; Maxim Healthcare Services, Inc.; CHG Management, Inc.; inVentiv Health; Cross Country Healthcare, Inc.; TeamHealth; Adecco Group; and Almost Family.

Healthcare Staffing Market Segmentation

Grand View Research has segmented the global healthcare staffing market based on service type and region:

Healthcare Staffing Service Type Outlook (Revenue, USD Million, 2016 - 2027)

• Travel Nurse Staffing
• Per Diem Nurse Staffing
• Locum Tenens Staffing
• Allied Healthcare Staffing

Healthcare Staffing Regional Outlook (Revenue, USD Million, 2016 - 2027)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
• Asia Pacific
  • Japan
  • China
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Neurovascular Devices Market Advanced Technologies and Growth Opportunities Worldwide By 2027

Neurovascular Devices Market Growth & Trends

The global neurovascular devices market size is anticipated to reach USD 3.9 billion by 2027, registering a CAGR of 5.6% over the forecast period, according to a new report by Grand View Research, Inc. Rising demand for minimally invasive procedures, increasing incidence of neurological disorders, and introduction of technologically advanced products are driving the growth of neurovascular devices.

Increasing incidence of neurological conditions such as stroke and brain aneurysm, cerebral artery stenosis, and stroke are fueling the market growth. For instance, according to the Stroke Association, more than 100,000 people suffer from stroke every year in U.K. and stroke costs are up to USD 33.7 billion per year.

Decreased postoperative pain and speedy recovery are leading to increasing adoption of minimally invasive surgeries and triggering growth of R&D in this field. Several key players are investing in R&D for the launch of innovative minimally invasive surgical instruments, especially got the neurovascular diseases. The endovascular coiling used for the treatment of intracranial aneurysm is one of the minimally invasive procedures widely recommended by the physicians.

Furthermore, increasing number of technologically advanced product launches by the key market players are also contributing to the market growth. For instance, in January 2018, CERENOVUS, launched Galaxy G3 mini coil, the softest and smallest embolic finishing coil used in the treatment of hemorrhagic stroke and intracranial aneurysm.

Request a free sample copy or view report summary: Neurovascular Devices Market Report

Neurovascular Devices Market Report Highlights

• The cerebral embolization and aneurysm coiling devices segment dominated the neurovascular devices market in 2019 owing to increasing demand for minimally invasive procedures and rising incidence of cerebral artery stenosis
• Based on therapeutic application, the stroke segment dominated the market in 2019 owing to increasing prevalence of stroke worldwide, awareness initiatives by various government and non-government organizations, and introduction of technologically advanced products
• North America dominated the market with the highest revenue share in 2019 owing to increasing prevalence of stroke and brain aneurysm, increasing disposable income, and presence of key players in the region
• Some of the major players operating in the market are Medtronic; Microport Scientific Corporation; Penumbra, Inc.; Stryker; Johnson and Johnson Services Inc.; Microvention Inc.; and Codman Neuro

Neurovascular Devices Market Segmentation

Grand View Research has segmented the global neurovascular devices market on the basis of device, therapeutic application, and regions:

Neurovascular Devices Outlook (Revenue, USD Million, 2016 - 2027)

• Cerebral Embolization and Aneurysm Coiling Devices
  • Embolic Coils
  • Flow Diverters
  • Liquid Embolic Agents
• Cerebral Angioplasty and Stenting Systems
  • Carotid Artery Stents
  • Embolic Protection
• Neurothrombectomy Devices
  • Clot Retrieval
  • Suction
  • Vascular Snares
• Support Devices
  • Micro Catheters
  • Micro Guidewires

Neurovascular Devices Therapeutic Application Outlook (Revenue, USD Million, 2016 - 2027)

• Stroke
• Cerebral Artery Stenosis
• Cerebral Aneurysm
• Others

Neurovascular Devices Regional Outlook (Revenue, USD Million, 2016 - 2027)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
• Latin America
  • Mexico
  • Brazil
  • Argentina
  • Colombia
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Fiducial Markers Market Is Projected To Reach Approximately USD 142.0 Million By 2027: Grand View Research Inc.

The global fiducial markers market size is estimated to reach USD 142.0 million by 2027 registering a CAGR of 4.2%, according to a new report by Grand View Research, Inc. Increasing prevalence of cancer and growing adoption of radiotherapy procedures are the factors expected to contribute to the market growth. Fiducial markers are widely used in external beam radiotherapy procedures. Therefore, increasing number of external beam radiotherapy procedures is also expected to boost the adoption of these markers. In addition, over most of the cancer patients receive radiation therapy, which in turn, is increasing the product demand.

Rising awareness about the safety and efficiency of advanced radiotherapy techniques, such as stereotactic radiosurgery, intensity-modulated radiotherapy, and image guide radiotherapy, in cancer treatment is expected to boost the market growth. Moreover, several initiatives undertaken by various governments for the development of new radiotherapy centers through direct funding or tax waive-off will aid in market growth.

On the other hand, availability of alternative treatment methods, such as chemotherapy, hormonal therapy, and surgery, is expected to have a negative impact on the product demand. Furthermore, with the advent of advanced imaging modalities, such as PET-based LINAC system, eliminates the need for fiducial markers hampering the market growth. However, high cost of PET-based LINAC systems is expected to contribute to the increased usage of fiducial markers for radiotherapy.

To request a sample copy or view summary of this report, click the link below:
https://www.grandviewresearch.com/industry-analysis/fiducial-markers-market

Further key findings from the study suggest:

• Gold fiducial markers segment held the largest market share in 2019 and is expected to expand at a healthy CAGR over the forecast period owing to product advantages, such as biocompatibility and enhanced visibility across multiple imaging modalities including CT, MRI, ultrasound, and fluoroscopy.
• Based on application, prostate cancer segment held the largest market share in 2019 and is expected to register a significant CAGR over the forecast period.
• Based on end user, radiotherapy center segment is projected to register the fastest CAGR during the forecast period.
• North America is estimated to be the largest regional fiducial markers market over the forecast period due to growing number of cancer cases and adoption of advanced technologies.
• Some of the prominent companies in the global market are CIVCO Radiotherapy; IZI Medical Products, LLC; Naslund Medical AB; Medtronic PLC; QlRad, Inc.; QFIX; Boston Scientific Corp.; Nanovi A/S; Eckert & Ziegler; and IBA Dosimetry GmbH.

Grand View Research has segmented the global fiducial markers market on the basis of product, modality, application, end user, and region:

Fiducial Markers Product Outlook (Volume, Units; Revenue, USD Million, 2016 - 2027)

• Gold
• Gold Combination
• Polymer
• Other Metal
• Liquid

Fiducial Markers Modality Outlook (Revenue, USD Million, 2016 - 2027)

• CT/CBCT
• MRI
• Ultrasound
• X-Ray

Fiducial Markers Application Outlook (Revenue, USD Million, 2016 - 2027)

• Breast Cancer
• Lung Cancer
• Prostate Cancer
• Head and Neck Cancer
• Other

Fiducial Markers End User Outlook (Revenue, USD Million, 2016 - 2027)

• Hospitals
• Radiotherapy Center
• Academic and Research Center

Fiducial Markers Regional Outlook (Revenue, USD Million, 2016 - 2027)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Switzerland
  • The Netherlands
  • Sweden
  • Belgium
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Thailand
  • Indonesia
  • Philippines
  • Taiwan
  • Malaysia
  • Singapore
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Chile
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
  • Israel

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Demand Optical Preclinical Imaging Market Increasing in Most Part of World 2027

The global optical preclinical imaging market size is expected to reach USD 543.0 million by the end of 2027, expanding at a CAGR of 3.3%, according to a new report by Grand View Research, Inc. Increasing number of preclinical studies aimed to study and develop various effective therapeutics for different diseases is a major factor boosting the adoption of optical preclinical imaging systems.

For instance, in December 2018, Bugworks Research, a drug discovery startup based in India, received US$ 3 million grant from CARB-X, a Boston-based organization. The grant was offered to support the development of preclinical trail for novel molecules to fight antimicrobial resistance. Moreover, various researchers are engaged in finding novel ways to increase the reproducibility and robustness of preclinical cancer research with an aim to reduce the failure rate of oncology clinical trials. Optical imaging also allows cost-effective and high-throughput animal study as compared to small animal molecular imaging technologies, including PET and MRI systems.

To request a sample copy or view summary of this report, click the link below:
https://www.grandviewresearch.com/industry-analysis/optical-preclinical-imaging-market

Further key findings from the study suggest:

• North America accounted for the largest share in 2019 owing to well-established research infrastructure, adoption of guidelines for preclinical research, product approvals, and higher number of drug development projects
• Based on product type, in the device segment, bioluminescence captured the largest optical preclinical imaging market share in 2019 owing to high sensitivity and broad dynamic range as compared to other techniques for imaging animals used in various studies
• The bioluminescence segment is expected to witness significant growth over the forecast period due to increasing adoption of bioluminescence technology to visualize and study disease processes in laboratory animals
• By end use, the pharma and biotech companies segment accounted for the largest optical preclinical imaging market share in 2019 owing to increasing number of candidates in drug development studies and increasing focus on research and development for drug development and innovation
• The research institutes segment is expected to witness the fastest growth during the forecast period owing to rising adoption of advanced optical imaging systems in the research institutes
• Leading players operating in the market for optical preclinical imaging include Bruker; Perkin Elmer, Inc.; MR Solutions; BioTek Instruments, Inc.; Milabs B.V.; Fujifilm Holdings Corporation; Magnetic Insight, Inc.; MBF Bioscience; and Mediso Ltd.

Grand View Research has segmented the global optical preclinical imaging market on the basis of product type, end use, and region:

Optical Preclinical Imaging Product Type Outlook (Revenue, USD Million, 2016 - 2027)

• Device
  • Fluorescence
  • Bioluminescence
• Consumables
  • Fluorescence
    • Green fluorescent proteins
    • Red fluorescent proteins
    • Infrared dyes
    • Others
  • Bioluminescence
    • Luciferins
    • Proluciferins
    • Coelenterazine
    • Others
  • Software

Optical Preclinical Imaging End-use Outlook (Revenue, USD Million, 2016 - 2027)

• Pharma and Biotech Companies
• Research Institutes
• Others

Optical Preclinical Imaging Regional Outlook (Revenue, USD Million, 2016 - 2027)

• North America 
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
  • Malaysia
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Columbia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Qatar

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Biohazard Bag Market Expected to Deliver Dynamic Progression By 2027

The global biohazard bags market size is anticipated to reach USD 472.3 million by 2027, expanding at a CAGR of 5.7% over the forecast period, according to a new report by Grand View Research, Inc. Growing population base, increasing awareness regarding the critical role of waste disposal in controlling human infection, and the rising hospital/healthcare standards in developing countries have together contributed to the market growth.

Waste disposal in biohazard bags is a critical step in maintaining the healthcare safety standards of medical institutions. Medical waste disposal in biohazard bags ensures that infectious waste isn’t exposed to the public and are disinfected or sterilized in a proper manner. Increasing awareness regarding hospital safety standards and investments by hospitals in maintaining their cleanliness are leading to increased use of biohazard bags, thereby propelling the biohazard bag market growth over the forecast period.

Biohazard bags allow proper handling of medical waste as the material used to handle medical waste needs to be tough, economical, and capable of creating an unbreakable containment. HDPE (High Density Polyethylene), LDPE (Low Density PolyEthylene), cellophane, and polyproylene are some commonly used materials for manufacturing biohazard bags. The materials and designs are generally autoclave safe, allowing them to be sterilized before disposal.

To request a sample copy or view summary of this report, click the link below:
https://www.grandviewresearch.com/industry-analysis/bio-hazards-bag-market

Further key findings from the study suggest:

• On the basis of material type, LDPE dominated the market in 2019 as they are most commonly used owing to their high strength, low material cost, flexibility, considerable durability, and transparency
• Based on application, the others segment accounted for the largest share in 2019 and is anticipated to witness significant growth over the forecast period owing to rising awareness among housekeeping staff about disposing infectious wastes in medical institutions
• Hospitals and diagnostic labs are expected to witness the fastest growth over the forecast period owing to growing patient population, public awareness about healthcare, and resulting increasing demand for routine diagnostic testing/routine check-ups
• Middle East & Africa is expected to witness the fastest growth over the forecast period, closely followed by Asia Pacific owing to increasing awareness regarding the need to properly dispose hazardous medical waste and constantly improving healthcare facilities in the region
• Key players in the biohazard bags market include Bel-Art SP Scienceware, Dynalon, Heathrow, Thermo Scientific, MiniGrip, TufPak, Cole-Parmer, and Fisher Scientific.

Grand View Research has segmented the global biohazard bag market on the basis of product material, application, end use, and region:

Biohazard Bags Product Material Type Outlook (Revenue, USD Million, 2016 - 2027)

• HDPE
• LDPE
• Cellophane
• Polypropylene

Biohazard Bags Application Outlook (Revenue, USD Million, 2016 - 2027)

• Highly infectious
• Other Infectious
• Sharps
• Chemical & Pharmaceutical
• General Healthcare Waste
• Others

Biohazard Bags End-Use Outlook (Revenue, USD Million, 2016 - 2027)

• Hospitals
• Clinics
• Diagnostic Laboratories
• Pharmaceutical/Research Laboratories
• Others

Biohazard Bags Regional Outlook (Revenue, USD Million, 2016 - 2027)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • ROE
• Asia Pacific
  • Japan
  • China
  • South Korea
  • India
  • Australia
  • Thailand
  • Indonesia
  • ROAPAC
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Columbia
  • ROLATAM
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Turkey
  • Egypt
  • ROMEA

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

End Stage Renal Disease Market Valuation to Reach USD 172.0 Billion by the end of 2027

End Stage Renal Disease Market Growth & Trends

The global end stage renal disease market size is anticipated to reach USD 172.0 billion by 2027, exhibiting a CAGR of 12.4% over the forecast period, according to a new report by Grand View Research, Inc. Increasing number of patients suffering from kidney failure or end stage renal disease and rising prevalence of hypertension and diabetes are driving the market for end stage renal disease.

Chronic kidney disease (CKD) is one of the major causes of increase in the kidney failure rates among patients. According to the Centers for Disease Control and Prevention (CDC), approximately 37 million people in U.S suffer from CKD, whereas globally more than 500 million people (12-18% of world population) are affected. Moreover, at present, the highest prevalence rate of CKD is in China, U.S., Taiwan, Japan, Germany, France, Belgium, Africa, and Rest of Asia. It is also estimated that the number of cases of end stage renal disease or CKD will increase among the elderly population, especially in developing countries, such as China, India, and countries in Africa.

Technological advancements in the treatment of renal failure is another factor expediting the overall market growth. For instance, wearable artificial kidney (WAK) is a portable dialysis device designed to enable patients to live healthier as it controls blood pressure, improves clearance of wastes from the blood, and allows end stage renal disease or CKD patient for a less strict diet, resulting in lower fluid weight gain with less stress on the heart. Thus, WAK has the potential to reduce mortality in dialysis patients, thereby improving an end stage renal disease patient’s quality of life. The WAK prototypes designed and patented by innovative firms have been approved for human clinical trials by the U.S. FDA in 2016 with great success.

Key players in the market for end stage renal disease include Nipro Corporation; Fresenius Medical Care AG & Co. KGaA; Baxter International, Inc.; Medtronic Plc; B. Braun Melsungen AG; BD; Asahi Kasei Medical Co., Ltd; Cantel Medical; Nikkiso Co., Ltd; and JMS Co. Ltd. For instance, in October 2019, Fresenius Medical Care has received breakthrough device designation by U.S. FDA for its new hemodialysis machine that aims to prevent blood clotting without the use of any medication.

Request a free sample copy or view report summary: End Stage Renal Disease Market Report

End Stage Renal Disease Market Report Highlights

• Based on treatment, the dialysis segment dominated the market for end stage renal disease in 2019 owing to its ease of use and emergency convenience
• Asia Pacific led the market in 2019 owing to the large population of patients with CKD/ESRD and higher incidence of hypertension and diabetes in the region
• Key players operating in the market include Nipro Corporation; Fresenius Medical Care AG & Co. KGaA; Baxter International, Inc.; Medtronic Plc; B. Braun Melsungen AG; BD; Asahi Kasei Medical Co., Ltd; Cantel Medical; Nikkiso Co., Ltd; and JMS Co. Ltd.

End Stage Renal Disease Market Segmentation

Grand View Research has segmented the global end stage renal disease market on the basis of treatment and region:

End Stage Renal Disease Treatment Outlook (Revenue, USD Million, 2016 - 2027)

• Transplantation
• Dialysis
  • Peritoneal Dialysis
  • Hemodialysis
  • Wearable Artificial Kidney

End Stage Renal Disease Regional Outlook (Revenue, USD Million, 2016 - 2027)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific (APAC)
  • Japan
  • China
  • India
  • Australia
  • South Korea
• Latin America (LATAM)
  • Mexico
  • Brazil
  • Argentina
  • Colombia
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Intragastric Balloon Market to Expand at a CAGR of 12.1% Through 2027

The global intragastric balloon market size is expected to reach USD 90.5 million by 2027, expanding at a CAGR of 12.1% over the forecast period, according to a new report by Grand View Research, Inc. Rise in obesity and increasing demand for minimally invasive procedures are the key factors driving the market.

Intragastric balloons are one of the most widely adopted endoscopic bariatric therapy devices in the clinical settings. This can be attributed to complications associated with surgical weight loss treatments and the low eligibility criteria for surgical options, thus leading to a rise in demand for effective minimally invasive weight-loss treatment options.

Safety concerns associated with intragastric balloons are anticipated to make the regulatory framework more stringent for pre-market and post-market scrutiny process of these devices. For instance, in 2019, Apollo Endosurgery Inc. revised the labeling of its Orbera intragastric balloon system to include contradiction clarifications, precautions related to anticholinergic and psychotropic medications, and updated U.S. adverse event tables after it received FDA safety letter.

Nonetheless, extensive research activities related to the development of innovative and novel systems and up-gradation of existing intragastric balloons to overcome the shortcomings of the traditional systems are anticipated to facilitate the intragastric balloon market growth.

To request a sample copy or view summary of this report, click the link below:
https://www.grandviewresearch.com/industry-analysis/intragastric-balloon-market

Further key findings from the study suggest:

• According to the American Society for Metabolic and Bariatric Surgery (ASMBS) data, nearly 5,000 intragastric balloon implantations have been conducted since the U.S. FDA approval
• The single balloon type segment held the largest share in the market in 2019. The triple type is expected to witness significant growth over the forecast period
• By filling material, gas-filled systems are anticipated to witness lucrative growth over the forecast period
• Based on end use, hospitals held a significant share in 2019. Ambulatory surgical centers are expected to witness considerable growth from 2020 - 2027
• On the basis of administration, endoscopy held the dominant market share in 2019. Pill form is expected to witness lucrative growth over the forecast period
• North America dominated the intragastric balloon market in 2019 due to the presence of a large obese population and high adoption of bariatric procedures. Asia Pacific is expected to witness remunerative growth over the forecast period
• Some of the key companies operating in the market are Apollo Endosurgery, Inc.; Obalon Therapeutics, Inc; ReShape Medical, Inc; Allurion Technologies, Inc.; Spatz3; Helioscopie; Endalis; MEDSIL; and Lexel Medical
• As of January 2019, Apollo Endosurgery, Inc. has discontinued the sales and distribution of its ReShape Balloon.

Grand View Research has segmented the global intragastric balloon market on the basis of administration, balloon type, filling material, end use, and region:

Intragastric Balloon Administration Outlook (Revenue, USD Million, 2016 - 2027)

• Pill Form
• Endoscopy

Intragastric Balloon Type Outlook (Revenue, USD Million, 2016 - 2027)

• Single
• Dual
• Triple

Intragastric Balloon Filling Material Outlook (Revenue, USD Million, 2016 - 2027)

• Saline Filled
• Gas Filled

Intragastric Balloon End-use Outlook (Revenue, USD Million, 2016 - 2027)

• Hospitals
• Clinics
• Ambulatory Surgical Centers

Intragastric Balloon Regional Outlook (Revenue, USD Million, 2016 - 2027)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
  • The Netherlands
  • Belgium
  • Switzerland
  • Turkey
  • Poland
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Thailand
  • Indonesia
  • Malaysia
  • Philippines
  • Singapore
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Chile
  • Colombia
• MEA
  • South Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Egypt

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Telemedicine Market is Expected to Grow at a CAGR of 15.1% over the Forecast Period

The global telemedicine market size is expected to reach USD 155.1 billion by 2027, expanding at a CAGR of 15.1% over the forecast period, according to a new report by Grand View research, Inc. Increasing incidences of chronic conditions and rising demand for self-care medicines are the key factors driving the market. Furthermore, increasing use of internet applications, ease of telemedicine, and rising demand for centralization of healthcare are expected to help save cost, which is one of the critical factors for the telemedicine market growth.

The healthcare industry is enormously huge and its centralization is expected to help in harmonizing the entire process as well as providing economic assistances. The unprecedented outbreak of COVID-19 across the globe has resulted into increased demand for telemedicine solutions, due to lockdown implemented by several countries as a preventive measure to curb the pandemic.

Moreover, owing to their capability to monitor various chronic conditions such as diabetes, cardiovascular conditions, and cancer, telemedicine solutions are expected to experience substantial development in the coming years. Growing prevalence of cardiac conditions, increase in geriatric population, and the constant demand for self-governing by patients are the high impact rendering drivers of this industry.

Telemedicine is helping in reducing the emergency room visits and hospitalization rate, thereby augmenting the market growth. Moreover, improving therapeutic infrastructure, growing post-acute care supervision, and rising demand in the emerging economies are expected to further propel the demand. 

To request a sample copy or view summary of this report, click the link below:
https://www.grandviewresearch.com/industry-analysis/telemedicine-industry

Further key findings from the study suggest:

• The products sub-segment registered largest revenue share in 2019 due to increasing adoption of remote monitoring devices
• Telemedicine found wide applications in dermatology, psychiatry, intensive care units, emergency care, ophthalmology, and radiology, out of which, teleradiology accounted for the majority of revenue in 2019
• Web/mobile based delivery model is expected to witness significant growth in coming years due to high adoption of smartphones and penetration of internet
• The tele-homecare segment is anticipated to expand at a lucrative CAGR in coming years due to increasing awareness regarding remote healthcare benefits among patients and introduction of advanced technologies to remotely monitor patient’s health
• The provider end-use segment held the dominant share of overall market in 2019. Government initiated healthcare programs across the world are anticipated to propel the adoption of telemedicine solutions by patients and providers in coming years
• North America dominated the global telemedicine market in 2019 and is still dominating as there is high adoption of telehealth solution due to COVID-19 pandemic. Availability of advanced healthcare facilities along with funds for the emergency care delivery in order to stop the spread of the disease is contributing toward regional growth
• Asia Pacific is predicted to witness lucrative growth over the forecast period owing to developing economies such as China and India facing challenges to provide access to patients due to corona outbreak. Economic reforms, booming IT industry, and low functioning costs are the key factors attracting market players in this region
• Some of the key players in the market are IBM; Intel Corporation; Teladoc; Doctor on Demand; iCliniq; Philips Healthcare; McKesson Corporation; AMD Telemedicine; and Cardio Net Inc.

Grand View Research has segmented the global telemedicine market by component, technology, application, delivery model, type, end use, and region:

Telemedicine Component Outlook (Revenue, USD Million, 2016 - 2027)

• Product
  • Hardware
  • Software
  • Others
• Services
  • Tele-consulting
  • Tele-monitoring
  • Tele-education

Telemedicine Technology Outlook (Revenue, USD Million, 2016 - 2027)

• Store and Forward
• Real Time
• Others

Telemedicine Application Outlook (Revenue, USD Million, 2016 - 2027)

• Teleradiology
• Telepsychiatry
• Telepathology
• Teledermatology
• Telecardiology
• Others

Telemedicine Delivery Model Outlook (Revenue, USD Million, 2016 - 2027)

• Web/Mobile
  • Telephonic
  • Visualized
• Call Centers

Telemedicine Type Outlook (Revenue, USD Million, 2016 - 2027)

• Tele-hospital
• Tele-home

Telemedicine End Use Outlook (Revenue, USD Million, 2016 - 2027)

• Providers
• Payers
• Patients
• Others

Telemedicine Regional Outlook (Revenue, USD Million, 2016 - 2027)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Switzerland
  • Sweden
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Singapore
  • Malaysia
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Artificial Intelligence In Healthcare Market to Surpass USD 31.3 Billion by 2025

Artificial Intelligence in Healthcare Market Growth & Trends

The global artificial intelligence in healthcare market size is expected to reach USD 31.3 billion by 2025, growing at a CAGR 41.5% over a forecast period, according to a new report by Grand View Research, Inc. The rising demand to reduce healthcare costs, increasing adoption of precision medicine, growing importance of big data in healthcare, and declining hardware costs are some factors propelling adoption of AI technology in healthcare industry. Moreover, rise in potential applications of AI-based tools in medical care and growth in venture capital investments are anticipated to aid growth over the forecast period.

Rise in the number of cross-industry collaborations is anticipated to fuel growth. For instance, in March 2018,Microsoft announced partnership with Apollo Hospitals, one of the prominent healthcare systems in India. The partnership was focused on developing and deploying new machine learning models for predicting the risk of developing cardiac diseases and aid doctors in treatment planning. Increase in venture capital funding is a key factor propelling growth of AI start-ups, which is further contributing to market growth.

The adoption of AI in healthcare is increasing, as healthcare providers are focused on enhancing patient care further. The adoption of this technology in healthcare has various benefits, both patients and healthcare providers. AI enables personalized care, based on body constitution and past medical history. Moreover, the shortage of physicians in some countries is anticipated to increase demand for AI in healthcare.

Request a free sample copy or view report summary: Artificial Intelligence in Healthcare Market Report

Artificial Intelligence in Healthcare Market Report Highlights

• In 2018, software solutions held the largest revenue share owing to the development of AI-based software solutions for the healthcare sector
• Clinical trials held the largest revenue share in 2018, and this can be attributed to the growing focus of pharmaceutical companies on incorporating AI in automation of clinical trial processes.
• North America held the largest revenue share, owing to high adoption of healthcare IT solutions in the region and availability of well-established healthcare infrastructure
• Asia Pacific is expected to exhibit the fastest CAGR over the forecast period, owing to growing AI-based start-ups, improving healthcare IT infrastructure, and increasing adoption of advanced technologies.
• Some key players are IBM Corporation; NVIDIA Corporation, Nuance Communications, Inc.; Microsoft; Intel Corporation; and DeepMind Technologies Limited

Artificial Intelligence in Healthcare Market Segmentation

Grand View Research has segmented the artificial intelligence in healthcare market on the basis of component, application, and region:

Artificial Intelligence in Healthcare Component Outlook (Revenue, USD Million, 2014 - 2025)

• Software Solutions
• Hardware
• Services

Artificial Intelligence in Healthcare Application Outlook (Revenue, USD Million, 2014 - 2025)

• Robot Assisted Surgery
• Virtual Assistants
• Administrative Workflow Assistants
• Connected Machines
• Diagnosis
• Clinical Trials
• Fraud Detection
• Cybersecurity
• Dosage Error Reduction

Artificial Intelligence in Healthcare Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
  • US.
  • Canada
• Europe
  • UK,
  • Germany
  • Spain
  • Italy
  • Russia
  • France
• Asia Pacific
  • Australia
  • Japan
  • South Korea
  • India
  • China
  • Singapore
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • UAE
  • Saudi Arabia

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Veterinary Pain Management Market to Reflect a Significant CAGR of 5.3% by 2026

The Report Veterinary Pain Management Market Size, Share & Trends Analysis Report By Product (NSAIDs, Anesthetics), By Indication, By Animal Type (Companion, Livestock), By End Use, And Segment Forecasts, 2019 - 2026

The global veterinary pain management market size is expected to reach USD 1.73 billion by 2026, according to a new report by Grand View Research, Inc. It is projected to register a CAGR of 5.3% during the forecast period. Growing companion adoption and incidence of veterinary diseases is expected to boost the growth. Moreover, increasing income in the developing countries is another growth driver. For instance, according to the American Veterinary Medical Association (AVMA) in 2017, around 46% household had multiple types of pets in U.S.

North America held the dominant share of the veterinary pain management market in 2018, due to the favorable pet insurance policies and strategic initiatives adopted by various companies operating in the region. For instance, in August 2018, Zoetis Inc. acquired Abaxis in a probe to expand its veterinary products portfolio.

Increasing number of veterinary practitioners are anticipated to create growth opportunities in the market. High prevalence of chronic diseases such as cancer, diabetes, and osteoarthritis among others. These factors are projected to propel the market in the forthcoming years.

Furthermore, key players are implementing newer strategies such as product launch, merger and acquisitions, regional expansions etc. for increasing their foothold in the market. For instance, in March 2016, Dechra Pharmaceuticals acquired Putney in order to improve its animal product portfolio. In October 2018, Boehringer Ingelheim invested USD 80 million for R&D pertinent to veterinary vaccines in France. Moreover, increasing pet insurance coverage are further fueling the market growth.

Access Research Report of Veterinary Pain Management Market @ https://www.grandviewresearch.com/industry-analysis/veterinary-pain-management-market

Further key findings from the report suggest:

• NSAIDs accounted for the largest market share in terms of revenue in 2018, owing to the increasing incidence of chronic diseases
• Companion animal segment is expected to exhibit lucrative growth over the forecast period owing to rise in pet adoption and expenditure for better pet care
• Osteoarthritis (OA) segment is expected to hold the largest market share in terms of revenue due to increasing incidence of obesity which propels the risk for OA
• Post-operative pain segment is expected to exhibit lucrative growth over the forecast period due to the increasing number of surgeries for chronic disorders
• Asia Pacific is anticipated to witness lucrative growth due to rise in pet adoption and expendable income, especially in Japan and India
• Some of the key companies operating in the veterinary pain management market are Zoetis, CEVA, Boehringer Ingelheim GmbH, Bayer, Merck, and Elanco.

Grand View Research has segmented the global veterinary pain management market on the basis of product, indication, animal type, end use, and region:

Veterinary Pain Management Product Outlook (Revenue, USD Million, 2014 - 2026)

• NSAIDs
• Anesthetics
• Opioids
• Others

Veterinary Pain Management Indication Outlook (Revenue, USD Million, 2014 - 2026)

• Osteoarthritis
• Post-operative pain
• Others

Veterinary Pain Management Animal Type Outlook (Revenue, USD Million, 2014 – 2026

• Livestock animal
• Companion Animal

Veterinary Pain Management End Use Outlook (Revenue, USD Million, 2014 - 2026)

• Hospitals & Clinics
• Others

Veterinary Pain Management Regional Outlook (Revenue, USD Million, 2014 - 2026)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.